![](/img/cover-not-exists.png)
164TiP Phase I study of LOXO-101, a selective TRK inhibitor, in pediatric patients with cancer
Laetsch, T.W., Nagasubramanian, R., Dubois, S.G., Mascarenhas, L., Hawkins, D., Shukla, N., Turpin, B., Smith, S., Reynolds, M., Cruickshank, S., Donahue, L., Cox, M.C., Pappo, A.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw579.016
Date:
December, 2016
File:
PDF, 34 KB
english, 2016